keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Balixafortide TFA (POL6326 TFA) is a potent, selective CXCR4 antagonist that exhibits excellent tolerance levels and demonstrates an IC50 of less than 10 nM. It displays over 1000-fold selectivity for CXCR4 over a large panel of other receptors, including CXCR7. This compound effectively inhibits β-arrestin recruitment and calcium flux with IC50 values under 10 nM. Additionally, Balixafortide TFA serves as a powerful agent for mobilizing hematopoietic stem and progenitor cells (HSPC) and has documented anti-cancer effects [1] [2].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | Balixafortide TFA (POL6326 TFA) is a potent, selective CXCR4 antagonist that exhibits excellent tolerance levels and demonstrates an IC50 of less than 10 nM. It displays over 1000-fold selectivity for CXCR4 over a large panel of other receptors, including CXCR7. This compound effectively inhibits β-arrestin recruitment and calcium flux with IC50 values under 10 nM. Additionally, Balixafortide TFA serves as a powerful agent for mobilizing hematopoietic stem and progenitor cells (HSPC) and has documented anti-cancer effects [1] [2]. |
Molecular Weight | 1978.16 |
Formula | C86H119F3N24O23S2 |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Balixafortide TFA inhibitor inhibit